Why Ozempic is Generally Not a Disqualifier As of current medical guidelines, GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound are not listed as disqualifying medications
Remarkably, the efficacy that we are seeing with regards to changes in body weight are approaching what we see with bariatric surgery, something we discussed in detail in a previous webinar Underneath the lost kilos: weight loss in metabolic disease
Food noise is not a glitch
BPC-157 is believed to have anti-inflammatory properties that help modulate this response
Long-term use is determined by how well it fits each patient's needs
Choose the klow stack dosage when the research context is tissue repair, skin quality, and inflammation control rather than metabolic weight-management signaling